1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow F16IL2: new trials by email Literature Review of F16IL2 trials Research Report on F16IL2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation F16IL2, BI 836858 - Acute Myeloid Leukemia (AML) Relapse | Phase 1 | Completed | Philogen S.p.A. | 15 | 2016-12-02 | 2022-04-20 |
Leukemia, Myeloid, Acute (1) · Recurrence (1)
Philogen S.p.A. (1)
Germany (1)